Over $42 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Over $42 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mostly lower on Monday, there were a few notable insider trades.
儘管美國股市周一收盤大多走低，但仍有一些值得注意的內幕交易。
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
當業內人士購買股票時，表明他們對公司前景的信心，或者他們將股票視為便宜貨。無論哪種方式，這都標誌著有機會走多頭股票。內幕購買不應被視為作出投資或交易決定的唯一指標。在最好的情況下，它可以將信念借給購買決定。
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
以下是最近幾個值得注意的內幕購買。欲了解更多信息，請查看 本辛加的內幕交易 平台。
Acrivon Therapeutics
治疗学
- The Trade: Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Director Rajeev Shah acquired a total of 4,810,508 shares an average price of $12.50. To acquire these shares, it cost around $42.37 million.
- What's Happening: The company recently priced its initial public offering of 7,550,000 shares at $12.50 per share.
- What Acrivon Therapeutics Does: Acrivon Therapeutics is clinical stage biopharmaceutical company.
- 貿易： acrivon 治療, 公司. (納斯達克:ACRV) 導演拉傑夫沙 購入合共 4,810、508 股股份 平均價格為 12.50 美元。要收購這些股份，成本約為 4,237 萬元。
- 發生了什麼事： 該公司最近以每股 12.50 美元的價格定價為 7,550,000 股的首次公開發行。
- 什麼阿克里馮治療是做的： 艾克里芬治療是臨床階段生物製藥公司。
Ryan Specialty
瑞安特產
- The Trade: Ryan Specialty Holdings, Inc. (NYSE:RYAN) CEO Patrick Ryan acquired a total of 288,038 shares at an average price of $38.26. To acquire these shares, it cost around $11.02 million.
- What's Happening: The company recently posted Q3 results.
- What Ryan Specialty Does: Ryan Specialty Holdings Inc, formerly Ryan Specialty Group Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents and carriers.
- 貿易： 瑞安特殊控股有限公司 紐約證券交易所代碼：瑞安）首席執行官帕 在以下地區購入合共 288,038 股股份 的平均價格為 38.26 美元。要收購這些股份，它的成本約為 1,102 萬美元。
- 發生了什麼事： 該公司最近公布了第三季度的結果。
- 瑞安專業是做什麼： 瑞安特殊控股有限公司，前身瑞安特殊集團控股有限公司是為保險經紀人，代理商和運營商提供專業產品和解決方案的服務提供商
Don't forget to check out our premarket coverage here .
別忘了在這裡查看我們的售前保障。
Also check this: Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday
還要檢查這個：亞馬遜到 119 美元？以下是星期二的 5 個其他目標價格變化
Greenhill & Co
格林希爾有限公司
- The Trade: Greenhill & Co., Inc. (NYSE:GHL) Chairman and CEO Scott L Bok bought a total of 47,850 shares at an average price of $10.09. To acquire these shares, it cost around $482.99 thousand.
- What's Happening: Greenhill recently reported better-than-expected Q3 sales results.
- What Greenhill & Co Does: Greenhill & Co Inc is an independent investment bank that provides financial and strategic advice on significant domestic and cross-border mergers and acquisitions, divestitures, restructurings, financings, capital raising and other transactions to a diverse client base, including corporations, partnerships, institutions and governments globally.
- 貿易： 格林希爾股份有限公司 紐約證券交易所代碼：GHL）董事長兼首席執行官 Scott L Bok 買入合共 4 千 8 百五十股股票 平均價格為 10.09 美元。要收購這些股票，它的成本約為 482.99 萬美元。
- 發生了什麼事： 格林希爾最近報告的第三季度銷售業績好於預期。
- 格林希爾有限公司做了什麼： GreenHill & Co Inc 是一家獨立的投資銀行，為多元化的客戶群（包括全球企業、合作夥伴、機構和政府）等多元化的客戶群提供重要的國內和跨境併購、剝離、重組、融資、融資和其他交易的財務和戰略建議。
譯文內容由第三人軟體翻譯。